Renasant (RNST)
(Delayed Data from NYSE)
$35.00 USD
+0.47 (1.36%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $34.98 -0.02 (-0.06%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Renasant Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 910 | 691 | 696 | 734 | 696 |
Cost Of Goods | 232 | 35 | 29 | 54 | 82 |
Gross Profit | 678 | 656 | 667 | 680 | 614 |
Selling & Adminstrative & Depr. & Amort Expenses | 455 | 417 | 428 | 551 | 381 |
Income After Depreciation & Amortization | 223 | 239 | 239 | 128 | 233 |
Non-Operating Income | 0 | 1 | 0 | -7 | 0 |
Interest Expense | 46 | 25 | 16 | 17 | 17 |
Pretax Income | 177 | 211 | 223 | 103 | 216 |
Income Taxes | 33 | 45 | 47 | 20 | 48 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 145 | 166 | 176 | 84 | 168 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 145 | 166 | 176 | 84 | 168 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 258 | 282 | 286 | 163 | 241 |
Depreciation & Amortization (Cash Flow) | 35 | 43 | 47 | 35 | 8 |
Income After Depreciation & Amortization | 223 | 239 | 239 | 128 | 233 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 56.45 | 56.21 | 56.43 | 56.47 | 58.23 |
Diluted EPS Before Non-Recurring Items | 3.15 | 3.00 | 2.98 | 1.93 | 2.91 |
Diluted Net EPS (GAAP) | 2.56 | 2.95 | 3.12 | 1.48 | 2.88 |
Fiscal Year end for Renasant Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 258.97 | 254.56 | 230.79 | 243.88 | 214.39 |
Cost Of Goods | 87.62 | 82.61 | 77.17 | 70.91 | 51.39 |
Gross Profit | 171.35 | 171.95 | 153.62 | 172.97 | 163.00 |
SG&A, R&D, and Dept/Amort Expenses | 115.28 | 115.35 | 114.39 | 112.98 | 112.17 |
Income After SG&A, R&D, and Dept/Amort Expenses | 56.07 | 56.60 | 39.23 | 59.99 | 50.83 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 7.56 | 7.28 | 7.31 | 7.39 | 15.56 |
Pretax Income | 48.51 | 49.32 | 31.91 | 52.60 | 35.28 |
Income Taxes | 9.67 | 9.91 | 3.79 | 10.77 | 6.63 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 38.85 | 39.41 | 28.12 | 41.83 | 28.64 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 38.85 | 39.41 | 28.12 | 41.83 | 28.64 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 56.69 | 56.53 | 56.61 | 56.52 | 56.40 |
Diluted EPS Before Non-Recurring Items | 0.69 | 0.65 | 0.76 | 0.75 | 0.83 |
Diluted Net EPS (GAAP) | 0.69 | 0.70 | 0.49 | 0.74 | 0.51 |